RT Journal Article
T1 Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options.
A1 Agcaoglu, Orhan
A1 Sezer, Atakan
A1 Makay, Ozer
A1 Erdogan, Murat Faik
A1 Bayram, Fahri
A1 Guldiken, Sibel
A1 Raffaelli, Marco
A1 Sonmez, Yusuf Alper
A1 Lee, Yong-Sang
A1 Vamvakidis, Kyriakos
A1 Mihai, Radu
A1 Duh, Quan-Yang
A1 Akinci, Baris
A1 Alagol, Faruk
A1 Almquist, Martin
A1 Barczynski, Marcin
A1 Bayraktaroglu, Taner
A1 Berber, Eren
A1 Bukey, Yusuf
A1 Cakmak, Guldeniz Karadeniz
A1 Canturk, Nuh Zafer
A1 Canturk, Zeynep
A1 Celik, Mehmet
A1 Celik, Ozlem
A1 Ceyhan, Banu Ozturk
A1 Cherenko, Sergii
A1 Clerici, Thomas
A1 Coombes, David Scott
A1 Demircan, Orhan
A1 Deyneli, Oguzhan
A1 Dionigi, Gianlorenzo
A1 Emre, Ali Ugur
A1 Erbil, Yesim
A1 Filiz, Ali Ilker
A1 Gozu, Hulya Ilıksu
A1 Gurdal, Sibel Ozkan
A1 Gurleyik, Gunay
A1 Haciyanli, Mehmet
A1 Kebudi, Abut
A1 Kim, Seokmo
A1 Koutelidakis, Giannis
A1 Kuru, Bekir
A1 Mert, Meral
A1 Oruk, Guzide Gonca
A1 Ozbas, Serdar
A1 Palazzo, Fausto
A1 Pandev, Rumen
A1 Riss, Phillip
A1 Sabuncu, Tevfik
A1 Sahin, Ibrahim
A1 Sakman, Gurhan
A1 Saygili, Fusun
A1 Senyurek, Yasemin Giles
A1 Sleptsov, Ilya
A1 Van Slycke, Sam
A1 Teksoz, Serkan
A1 Terzioglu, Tarik
A1 Tezelman, Serdar
A1 Tunca, Fatih
A1 Ugurlu, Mustafa Umit
A1 Uludag, Mehmet
A1 Villar-Del-Moral, Jesus
A1 Vriens, Menno
A1 Yazici, Dilek
K1 Consensus
K1 Endocrine disease
K1 Expert opinion
K1 Pandemic
K1 Qualtrics
K1 Survey
AB The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic. We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire. Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole ± β-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma. This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible.
YR 2021
FD 2021-04-11
LK http://hdl.handle.net/10668/17559
UL http://hdl.handle.net/10668/17559
LA en
DS RISalud
RD Apr 7, 2025